Offer open to existing and new investors Opportunity to receive consistent and stable income stream paid via monthly distributions Neuberger...
Neuberger Berman, manager of the NB Global Corporate Income Trust (ASX:NBI), is pleased to announce its plans for a prospective offer of new...
Broadens Access to Global Fixed Income for Australian Clients Global investment manager Neuberger Berman announced that the capital raise by way...
Neuberger Berman is pleased to provide a market update on its prospective new offer of units for the NB Global Corporate Income Trust...
Neuberger Berman, manager of the NB Global Corporate Income Trust (ASX: NBI), is pleased to announce that NBI’s first half-yearly financial...
Neuberger Berman, manager of the newly listed NB Global Corporate Income Trust (“NBI”), is pleased to confirm that NBI has declared its first...
BETHESDA, Md., Nov. 26 /PRNewswire-FirstCall/ -- Micromet, Inc. (NASDAQ: MITI), a biopharmaceutical company developing novel, proprietary...
SAN DIEGO, Nov. 12 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (NASDAQ:HALO), a biopharmaceutical company developing and...
RICHMOND, Calif., May 21 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (NASDAQ:SGMO), a world-leader in the development and...
PALO ALTO, Calif., May 14 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced today announced that it has been...
REDWOOD CITY, Calif., May 14 /PRNewswire-FirstCall/ -- Maxygen, Inc. (NASDAQ:MAXY), a biotechnology company focused on the development of...
MEMPHIS, Tenn., May 15 /PRNewswire-FirstCall/ -- GTx, Inc. (NASDAQ:GTXI), the Men's Health Biotech Company, announced today that it will be...
CHESTER, N.J., May 15 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. (NASDAQ:ARXT) today announced that it was selected for...
NEW YORK, May 12 /PRNewswire-FirstCall/ -- The Nasdaq Stock Market, Inc. ("NASDAQ(R)") (NASDAQ:NDAQ) announced today the results of the...
BOTHELL, Wash., Nov. 14 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. (NASDAQ:NSTK), a leader in developing therapeutics using...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads